| Aim: The aim of the present study was to produce chrysin–curcumin-loaded PCL-PEG nanofibres by an
electrospinning technique and to evaluate the biological activity of the chrysin–curcumin-loaded PCLPEG
fibres for wound healing and its related genes using in vivo methods.
Materials and methods: The electrospinning method was carried out for the preparation of the
chrysin, curcumin and chrysin–curcumin-loaded PCL-PEG nanofibres with different concentrations. FTIR
and SEM were performed to characterize the chemical structures and morphology of the nanofibres. In
vitro drug release, as well as in vivo wound-healing studies were investigated in male rats. The expressions
of genes related to the wound-healing process were also evaluated by real-time PCR.
Results: Our study showed that the chrysin–curcumin-loaded nanofibres have anti-inflammatory properties
in several stages of the wound-healing process by affecting the IL-6, MMP-2, TIMP-1, TIMP-2 and
iNOS gene expression. Our results demonstrated that the effect of the chrysin-loaded nanofibre, the
curcumin-loaded nanofibre and the chrysin–curcumin-loaded nanofibre in the wound-healing process
is dose dependent and in accordance with the obtained results in that it might affect the inflammation
phase more than the other stages of the wound-healing process.
Conclusion: We have introduced chrysin–curcumin-loaded PCL-PEG nanofibres as a novel compound
for shortening the duration of the wound-healing process. |